Clinical Trials Directory

Trials / Completed

CompletedNCT03845062

Contribution of Drug Induced Sleep Endoscopy of Pediatric Obstructive Sleep Apnea Hypopnea Syndrome

Contribution of Drug Induced Sleep Endoscopy in the Management of Pediatric Obstructive Sleep Apnea Hypopnea Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The role of drug-induced sleep endoscopy (DISE) in the management of obstructive sleep apnea hypopnea syndrome (OSAHS) is not precisely defined for children. The primary objective of this study was to describe the consequences of DISE in the therapeutic management for children with OSAHS. The secondary objectives were to analyze the correlation between the number of obstructive sites found during DISE, the value of apnea-hypopnea index (AHI), and the type of OSAHS.

Detailed description

Retrospective single center study of 31 children (mean age: 5.5 ± 2.6 years) who benefited from DISE between 2015 and 2018 in the management of OSAHS. Modification of therapeutic management was noted. A correlation between the number of obstructive sites and the IAH on the one hand, and between the number of obstructive sites and the type of SAHOS on the other hand, was sought.

Conditions

Timeline

Start date
2015-10-01
Primary completion
2018-06-01
Completion
2018-08-01
First posted
2019-02-19
Last updated
2019-02-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03845062. Inclusion in this directory is not an endorsement.